Menieres

2 stories · following the connections

Business

Otonomy Holds Investor and Analyst Day and Provides Corporate Update

By Nasdaq OMXOct 7, 2016, 12:00 PM UTC

Business

Otonomy Announces Publication of OTIPRIO™ Phase 3 Clinical Trial Results in JAMA Otolaryngology

By Nasdaq OMXMar 18, 2016, 11:30 AM UTC